Trial Profile
Delayed Start vs Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 26 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 08 Mar 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.